Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential

Area of Science:

• Immunology
• Cell Therapy
• Regenerative Medicine

Background:

• Mesenchymal stem/stromal cells (MSCs) are multipotent cells with significant potential for allogeneic cell therapy.
• MSCs possess inherent immunomodulatory and trophic activities, alongside high in vitro self-renewal capabilities.
• Their functions can be engineered to enhance immunomodulatory effects, impacting various immune effector cells.

Purpose of the Study:

• To review the immunomodulatory aspects of both naïve and engineered MSCs.
• To explore the mechanisms by which MSCs modulate immune responses.
• To discuss strategies for optimizing MSC use in clinical settings.

Main Methods:

• Literature review of existing studies on MSC immunomodulation.
• Analysis of MSC interactions with immune cells (e.g., regulatory T cells, monocytes).
• Examination of MSC-secreted factors and cell-contact dependent mechanisms.

Main Results:

• MSCs modulate immune cell functions through direct contact and secreted factors.
• Both active and metabolically inactivated MSCs exhibit immunomodulatory potential.
• Regulatory T cells and monocytes are key players in MSC-mediated immune suppression.

Conclusions:

• MSCs are a promising cell therapy with broad immunomodulatory capabilities.
• Understanding MSC-immune cell interactions is crucial for therapeutic success.
• Engineering and strategic application of MSCs can enhance their clinical efficacy.